Current treatment options for recurrent nasopharyngeal cancer

Carlos Suarez, Juan P. Rodrigo, Alessandra Rinaldo, Johannes A. Langendijk, Ashok R. Shaha, Alfio Ferlito*

*Bijbehorende auteur voor dit werk

Onderzoeksoutputpeer review

106 Citaten (Scopus)


Loco-regional control rate of nasopharyngeal carcinoma (NPC) has improved significantly in the past decade. However, local recurrence still represents a major cause of mortality and morbidity in advanced stages, and management of local failure remains a challenging issue in NPC. The best salvage treatment for local recurrent NPC remains to be determined. The options include brachytherapy, external radiotherapy, stereotactic radiosurgery, and nasopharyngectomy, either alone or in different combinations. In this article we will discuss the different options for salvage of locally recurrent NPC. Retreatment of locally recurrent NPC using radiotherapy, alone or in combination with other treatment modalities, as well as surgery, can result in long-term local control and survival in a substantial proportion of patients. For small-volume recurrent tumors (T1-T2) treated with external radiotherapy, brachytherapy or stereotactic radiosurgery, comparable results to those obtained with surgery have been reported. In contrast, treatment results of advanced-stage locally recurrent NPC are generally more satisfactory with surgery (with or without postoperative radiotherapy) than with reirradiation.

Originele taal-2English
Pagina's (van-tot)1811-1824
Aantal pagina's14
TijdschriftEuropean Archives of Oto-Rhino-Laryngology
Nummer van het tijdschrift12
StatusPublished - dec.-2010

Citeer dit